{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Big Pharma to Face Off at Federal Circuit Oral Arguments Over Antibody Genus Patentability",
"url": "https://www.lexblog.com/2020/11/24/big-pharma-to-face-off-at-federal-circuit-oral-arguments-over-antibody-genus-patentability/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-YMFA501B",
"url": "https://www.lexblog.com/lib/YMFA501B/"
},
"datePublished": "2020-11-24T10:32:45-05:00",
"dateModified": "2020-11-24T07:46:49-05:00",
"author": {
"@type": "Person",
"name": "Caitlin M. Wilmot"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rothwell Figg"
},
"organizationScope": "at-publication",
"isPartOf": "Biosimilars Law Bulletin",
"about": "Intellectual Property",
"sourceUrl": "https://www.biosimilarsip.com/?p=5391",
"sourceStability": "may-move"
}